Raptor Pharma (NASDAQ: RPTP) announced that it has completed the acquisition of Quinsair™ (levofloxacin inhalation solution) from Tripex Pharmaceuticals. Quinsair is the first inhaled fluoroquinolone antibiotic approved in the European …
Disclosure: The author is short RPTP. The author wrote this article themselves, and it expresses their own opinions. The author is not receiving compensation for it. The author has no business relationship with any company whose stock is …
Raptor Pharmaceuticals (RPTP) - A corporation that researches existing drugs to improve them through specialized drug targeting methods was up over 20% today after Lazard rated them a new "buy" and slapped a $16 price target on the …
Raptor Pharmaceuticals Corp. RPTP entered into an agreement with Tripex Pharmaceuticals ... including up to $34.2 million of the closing consideration in its common stock. Moreover, Raptor will make payments of up to $350 million on …
RPTP), “lowering sales estimates with US market saturation and slow EU launch.” The specialists reiterated an Underperform rating and a $7 price target on the stock. The company is scheduled to report earnings on Thursday after …
RPTP), today announced that it has entered into an "At-the-Market" ("ATM") Sales Agreement, dated April 30, 2012, with Cowen and Company, LLC ("Cowen"), under which Raptor may, at its discretion, sell its common stock with a sales …
My fellow Minyanville Professor and co-founder of our firm ... Today, however, I want to focus on Raptor Pharmaceuticals (RPTP). Raptor's lead drug is DR Cysteamine for treatment of the orphan disease nephropathic cystinosis. Cystinosis …
The stock has moved down across its 200-day moving average of $129.60 today. Raptor Pharmaceutical (RPTP) is trading down on above-normal volume today, seeing a price drop on a volume of 1.2 million, or 4.1 times its average daily …
Wall Street opens lower as investors fret over rates PotashCorp (POT), Agrium (AGU) Enter Merger Agreement Starboard Value Targets Beaten-Down Perrigo (PRGO) - WSJ Horizon Pharma plc (HZNP) to Acquire Raptor Pharmaceutical …
Aug. 20, 2015 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) announced today that it has …